Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,473.47
(
0.37%
)
US TECH 100
28,612.40
(
0.11%
)
Dow Jones
50,579.70
(
0.58%
)
Brent Oil
101.17
(
0.00%
)
Bitcoin
77,221.17
(
0.69%
)
News Focus
News Focus
Post# of 257624
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123010
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 102689

Wednesday, 12/22/2010 6:54:56 PM

Wednesday, December 22, 2010 6:54:56 PM

Post# of 257624
FDA approves NVS’ triple-MoA hypertension pill consisting of Tekturna + Norvasc + HCTZ:

http://finance.yahoo.com/news/Novartis-Gains-FDA-Approval-prnews-28317699.html?x=0&.v=1

The brand name of the 3-in-1 pill is Amturnide (which contains a fragment of each of the three drug names).

NVS already sells a 2-in-1 pill consisting of Tekturna + Norvasc under the brand name, Tekamlo (#msg-53782319).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today